Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 68

Results For "ED"

9537 News Found

CDSCO approves Wockhardt’s Mignaf for treatment of community acquired bacterial pneumonia
Drug Approval | January 05, 2025

CDSCO approves Wockhardt’s Mignaf for treatment of community acquired bacterial pneumonia

Wockhardt plans to launch Miqnaf in the Indian market in coming few months


Godrej Agrovet launches Pride Hog feed range to boost pig health and immunity
News | January 04, 2025

Godrej Agrovet launches Pride Hog feed range to boost pig health and immunity

Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management


Veeda Group rebrands as Veeda Lifesciences
News | January 03, 2025

Veeda Group rebrands as Veeda Lifesciences

The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise


Akums commissions new manufacturing facility for Lyophilized and Sterile dosage
News | January 02, 2025

Akums commissions new manufacturing facility for Lyophilized and Sterile dosage

The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products


Huadong Medicine and SynerK to jointly develop a novel siRNA drug SNK-2726
R&D | January 02, 2025

Huadong Medicine and SynerK to jointly develop a novel siRNA drug SNK-2726

SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage


Venus Remedies secures GMP certification for antibiotic carbapenem facility in Moldova
Drug Approval | January 01, 2025

Venus Remedies secures GMP certification for antibiotic carbapenem facility in Moldova

Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026


Immedica to acquire biopharmaceutical company Marinus Pharmaceuticals
News | December 31, 2024

Immedica to acquire biopharmaceutical company Marinus Pharmaceuticals

Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million


Shilpa Medicare's Unit IV receives Eurasia GMP approval
Drug Approval | December 28, 2024

Shilpa Medicare's Unit IV receives Eurasia GMP approval

Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia


Venus Remedies partners with NSDC for workforce development through skill certification
News | December 27, 2024

Venus Remedies partners with NSDC for workforce development through skill certification

Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution